Clicky

BioXcel Therapeutics, Inc.(BTAI) News

Date Title
Jul 30 BioXcel Therapeutics to Report Second Quarter 2024 Financial Results on August 6, 2024
Jul 16 BioXcel Therapeutics Announces Preliminary Estimated Unaudited Second Quarter Net Revenues from Sales of IGALMI™ (dexmedetomidine) Sublingual Film
Jun 25 BioXcel Therapeutics Announces Positive Topline Results from Post-Marketing Requirement Study Evaluating PRN Treatment of IGALMI™ (dexmedetomidine) Sublingual Film for Agitation Associated with Bipolar Disorders or Schizophrenia
May 10 BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2024 Earnings Call Transcript
May 10 BioXcel Therapeutics First Quarter 2024 Earnings: Misses Expectations
May 10 Q1 2024 BioXcel Therapeutics Inc Earnings Call
May 9 BioXcel Therapeutics Reports First Quarter 2024 Financial Results
Apr 25 BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024
Apr 24 BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
Apr 22 BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential
Apr 10 BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia
Mar 25 BioXcel Therapeutics Announces $25 Million Registered Direct Offering
Mar 24 BioXcel Therapeutics Full Year 2023 Earnings: Revenues Disappoint
Mar 15 BioXcel Therapeutics Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
Mar 13 BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2023 Earnings Call Transcript
Mar 13 Q4 2023 BioXcel Therapeutics Inc Earnings Call
Mar 12 BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
Mar 7 7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
Nov 30 BioXcel Therapeutics to Host Virtual Neuroscience R&D Day on Dec. 12, 2023
Oct 31 BioXcel Therapeutics to Report Third Quarter 2023 Financial Results on November 14, 2023